Alina Ogizbayeva

Dr. Alina Ogizbayeva

NCJSC Karaganda Medical University, Karaganda, Kazakhstan
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
YTYermek Turgunov
Yermek Turgunov
Alina OgizbayevaAlina Ogizbayeva
Alina Ogizbayeva
SASofiko Assamidanova
Sofiko Assamidanova
DMDmitriy Matyushko
Dmitriy Matyushko
MMMiras Mugazov
Miras Mugazov
YSYerzhan Sharapatov
Yerzhan Sharapatov
Background/Objectives: The aim of this study was to evaluate potential biomarkers of bacterial translocation (lipopolysaccharide-binding protein (LBP) and soluble CD14 subtype (sCD14-ST)) and intestinal wall damage (intestinal fatty acid binding protein (I-FABP), Zonulin, and regenerating islet-derived protein-3α (REG3α)) in patients with multiple organ dysfunction syndrome (MODS). Methods: The study involved 327 patients divided into two groups: Group 1 comprised 227 patients with MODS (main group), while Group 2 comprised 100 patients with identical pathologies but without MODS (control group). To examine these biomarkers in the blood, venous blood was taken in the control group on the day of admission to the hospital, in patients with MODS on the first day of MODS staging, and later on Days 3 and 7 of its development. Levels of these markers in blood serum were determined by enzyme-linked immunosorbent assays according to the manufacturers’ instructions. Results: In the control group, values of all the investigated markers were lower than in the group of MODS patients (p < 0.0001). In the main group, the mortality rate was 44.9% (n = 102). The values of sCD14-ST on Day 1 and of I-FABP and REG3α on Days 1 and 3 were higher in deceased MODS patients (p < 0.05), while LBP levels on Day 7 were conversely lower in the deceased patients (p = 0.006). SOFA and APACHE II scores were higher in the deceased patients (p < 0.0001). Conclusions: In MODS patients, the increased I-FABP, REG3α, and sCD14-ST but decreased LBP levels may indicate increased intestinal wall permeability and bacterial translocation, which may exacerbate the course of multiple organ dysfunction and increase the risk of mortality. Despite the limitations of this study, the studied potential biomarkers can be considered noteworthy candidates for identifying MODS patients at high risk of mortality.

29 August 2023 in Asian Journal of Surgery
Verified
Journal Article
Open access
YTYermek Turgunov
Yermek Turgunov
Alina OgizbayevaAlina Ogizbayeva
Alina Ogizbayeva
KSKayrat Shakeyev
Kayrat Shakeyev
MMMiras Mugazov
Miras Mugazov
LALyudmila Akhmaltdiniva
Lyudmila Akhmaltdiniva
VRViktor Rudolf
Viktor Rudolf
The main aim of this study is to analyze changes in the lipopolysaccharide-binding protein (LBP) level in blood serum over time and assess it as a potential risk factor for the development of SIRS, infectious and inflammatory complications, organ dysfunction and mortality in patients operated on colorectal cancer (CRC). 90 CRC patients were divided into 2 groups: Group 1-50 patients operated on for CRC without acute bowel obstruction (ABO); Group 2-40 patients operated on for CRC with ABO. To determine LBP by ELISA method venous blood was taken 1 h before surgery and 72 h after it (3rd day). LBP level on the 3rd day after surgery was lower in CRC patients with SIRS, postoperative complications, organ dysfunction and in dead patients. With an LBP value on the 3rd day after surgery being at ≤821.95 ng/mL, the risk of SIRS occurrence is 3.5 times higher, that of the postoperative complications is 5.2 times higher and death is 12.9 times higher than with its higher level (OR 3.5, CI 1.46-8.4; OR 5.2, CI 1.80-15.12; OR 12.9, CI 1.54-108.21, respectively). If the LBP value on the 3rd day after surgery is ≤ 700.15 ng/mL, the risk of organ dysfunctions is 13.5 times higher than with its higher level (OR 13.5, CI 3.536-51.54). This study demonstrated that in the patients with CRC, the LBP can be used as a predictive criterion for the development of SIRS, postoperative infectious and inflammatory complications, organ dysfunction, and mortality.

1 January 2021 in Contemporary Oncology
Verified
Journal Article
Open access
PDF file
YTYermek Turgunov
Yermek Turgunov
Alina OgizbayevaAlina Ogizbayeva
Alina Ogizbayeva
LALyudmila Akhmaltdinova
Lyudmila Akhmaltdinova
KSKayrat Shakeyev
Kayrat Shakeyev
Introduction In this pilot study lipopolysaccharide-binding protein (LBP) levels were assessed as a possible risk factor for development of systemic inflammatory response syndrome (SIRS) and infectious and inflammatory complications in colorectal cancer (CRC) patients after surgery. Material...

31 December 2022 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
KSKayrat Shakeyev
Kayrat Shakeyev
YTYermek Turgunov
Yermek Turgunov
Alina OgizbayevaAlina Ogizbayeva
Alina Ogizbayeva
OAOlga Avdiyenko
Olga Avdiyenko
MMMiras Mugazov
Miras Mugazov
IAIlya Azizov
Ilya Azizov
Purpose: In this pilot study the dynamic of presepsin (soluble CD14 subtype, sCD14-ST) in blood serum was assessed as a possible risk factor for the development of systemic inflammatory response syndrome (SIRS) and infectious and inflammatory complications in operated colorectal cancer patients.Methods: To determine sCD14-ST by enzyme-linked immunosorbent assay method venous blood was taken 1 hour before surgery and 72 hours after it (3rd day). The presence of SIRS and organ dysfunctions (ODs) according to the Sequential Organ Failure Assessment scale were assessed.Results: Thiry-six patients with colorectal cancer were enrolled in the study. sCD14-ST level before surgery was 269.8±103.1 pg/mL (interquartile range [IQR], 196.7–327.1 pg/mL). Despite the presepsin level on the 3rd day being higher (291.1±136.5 pg/mL; IQR, 181.2–395.5 pg/mL), there was no statistical significance in its dynamics (P=0.437). sCD14-ST value both before surgery and on the 3rd day after it was significantly higher in patients with bowel obstruction (P=0.038 and P=0.007). sCD14-ST level before surgery above 330 pg/mL showed an increase in the probability of complications, SIRS, and OD (odds ratio [OR], 5.5; 95% confidence interval [CI], 1.1–28.2; OR, 7.0; 95% CI, 1.3–36.7; and OR, 13.0; 95% CI, 1.1–147.8; respectively). Patients with OD had higher levels on the 3rd day after surgery (P=0.049).Conclusion: sCD14-ST level in operated colorectal cancer patients was much higher if they were admitted with complication like bowel obstruction. Higher preoperative levels of sCD14-ST increase the probability of postoperative complications, SIRS, and OD. Therefore, further studies with large sample size are needed.

1 January 2024 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
YTYermek Turgunov
Yermek Turgunov
Alina OgizbayevaAlina Ogizbayeva
Alina Ogizbayeva
SASofiko Asamidanova
Sofiko Asamidanova
OAOlga Avdienko
Olga Avdienko
DADana Amanova
Dana Amanova
MMMiras Mugazov
Miras Mugazov
Introduction: The aim of this study was to evaluate the potential biomarkers of bacterial translocation: lipopolysaccharide‐binding protein (LBP) and soluble CD14 subtype (sCD14‐ST), and intestinal wall damage: intestinal fatty acid binding protein (I‐FABP), zonulin, and regenerating islet‐derived protein‐3α (REG3α), in the patients with multiple organ dysfunction syndrome (MODS).Methods: The study involved 78 patients over the age of 18 with MODS set according to the Sequential Organ Failure Assessment (SOFA) scale. Venous blood was sampled during diagnostics of MODS, on the 3rd and on the 7th day of its development. The sCD14‐ST, LBP, I‐FABP, REG3α, and zonulin in blood serum were determined by enzyme‐linked immunosorbent assay (ELISA).Results: Out of 78 patients with MODS, 43 patients survived (55.1%) and 35 patients died (44.9%). Levels of sCD14‐ST on Day 1, I‐FABP on Day 3, and REG3α on Days 3 and 7 and SOFA scores on Days 1, 3, and 7, Acute Physiology and Chronic Health Evaluation II (APACHE II) scores on Days 1, 3, and 7, and Modified Nutrition Risk in Critically Ill (mNUTRIC) scores on Days 1, 3, and 7 were statistically significantly higher in deceased patients (p < 0.05).Conclusion: In patients with MODS, an increase in sCD14‐ST, I‐FABP, and REG3α in blood serum can indicate the violation of intestinal barrier function and increased bacterial translocation, which ultimately may aggravate the severity of MODS and increase the risk of death. It is required to further study the factors leading to intestinal wall permeability disorders in order to screen for timely intensive care measures that can help reduce the stay of patients in the intensive care unit (ICU) as well as mortality.Trial Registration: ClinicalTrials.gov identifier: NCT06221293

19 April 2024 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Closed access
YTYe.M. Turgunov
Ye.M. Turgunov
Alina OgizbayevaAlina Ogizbayeva
Alina Ogizbayeva
MMMiras Mugazov
Miras Mugazov
SAS.G. Asamidanova
S.G. Asamidanova
Increased intestinal wall permeability and impaired barrier function in ICU patients are due to microcirculation disorders, ischemia and hypoxia of intestinal wall. As a result, bacteria and/or their endotoxins penetrate the damaged intestinal wall, enhance immune response and can lead to systemic inflammation, multiple organ dysfunction syndrome, sepsis and even death. This review is devoted to mechanisms of intestinal barrier disruption and the most effective serum biomarkers of intestinal wall damage: zonulin, intestinal fatty acid binding protein (I-FABP) and regenerating islet-derived 3-alpha (REG3α), citrulline. Despite various study limitations, these biomarkers are interesting candidates for identifying patients with high risk of complications and screening for timely intensive care measures. These approaches can reduce ICU-stay and mortality.